The effects of antibiotics on liver enzymes in pregnancy
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232410Keywords:
ALT, Antibiotics, AST, PregnancyAbstract
Background: Antibiotics are increasingly being prescribed during pregnancy. Even though safe non-teratogenic drugs are prescribed, due to altered pharmacokinetics during pregnancy can have adverse effects on hepatic metabolism.
Methods: This was a prospective analytical study conducted in the department of obstetrics and gynecology at ESIC Medical College and PGIMSR, Bengaluru, Bengaluru from August 2022 to January 2023, 62 pregnant women diagnosed with infection were admitted and evaluated for the effects of antibiotics on liver enzymes. All cases had undergone a baseline Liver function test before antibiotic therapy were compared and statistically analyzed with the liver enzymes, alanine transaminase (ALT), and aspartate transaminase (AST) values after 7 days of the antibiotic course.
Results: In this study, the mean age of pregnant women enrolled was 26±3.62 years. Both primi (45.2%) and multigravida (54.8%) were equally represented. The most commonly prescribed antibiotic was cefotaxime (67.7%). The mean pre AST was 17.92±11.28 and post-AST was 18.34±15.55 U/l (paired t-test =0.861) and the mean pre-ALT was 13.09±19.82 and post-AST was 11.7±8.01 U/l (paired t-test =0.533). Hence there were no significant changes in post-AST and post-ALT compared to Pre AST and ALT values.
Conclusions: In this study the common antibiotics administered were cephalosporins and they didn’t show any effects on AST or ALT values after completing the antibiotic course.
References
Kamath P, Kamath A, Ullal SD. Liver injury associated with drug intake during pregnancy. World J Hepatol. 2021;13(7):747-62.
Lao TT. Drug-induced liver injury in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2020;68:32-43.
Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052-62.
Low EXS, Zheng Q, Chan E, Lim SG. Drug induced liver injury: East versus West- a systematic review and meta-analysis. Clin Mol Hepatol. 2020;26(2):142-54.
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27(2):89-94.
Martinez de Tejada B. Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health. 2014;11(8):7993-8009.
David S, Hamilton JP. Drug-induced liver injury. US Gastroenterol Hepatol Rev. 2010;6:73-80.
Devarbhavi H. An update on drug-induced liver injury. J Clin Exp Hepatol. 2012;2(3):247-59.
Beck-Friis J, Studahl M, Yilmaz A, Andersson R, Lönnermark E. Increased risk of hepatotoxicity and temporary drug withdrawal during treatment of active tuberculosis in pregnant women. Int J Infect Dis. 2020;98:138-43.
Terrault NA, Williamson C. Pregnancy-associated liver diseases. Gastroenterology. 2022;163(1):97-117.
Li, X, Tang, J, Mao, Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 2022;42:1999-2014.
Li X, Gao P, Niu J. Metabolic comorbidities and risk of development and severity of drug-induced liver injury. Biomed Res Int. 2019;2019:8764093.
Bacq Y, Zarka O, Brechot J, Mariotte N, Vol S, Tichet J, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology. 1996;23(5):1030-4.
Bacq Y. The Liver in Normal Pregnancy. In: Madame Curie Bioscience Database. Austin (TX): Landes Bioscience; 2000-2013.
Lim E, Mouyis M, MacKillop L. Liver diseases in pregnancy. Clin Med. 2021;21(5):e441-5.
Cephalosporins, Parenteral. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
